BLBaoli Lin

Baoli Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baoli Lin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Qingguo Li

    Department of Neurosurgery, HuanHu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    2 shared publications
  • Ke Pu

    Department of Neurosurgery, HuanHu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    1 shared publication
  • Ke Pu

    Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin 300350, China; Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin 300350, China; Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China

    1 shared publication
  • Nanyue Peng

    Department of Neurosurgery, HuanHu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    1 shared publication
  • Nanyue Peng

    Department of Neurosurgery, HuanHu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    1 shared publication
  • Tao Fu

    Department of Neurosurgery, HuanHu Hospital Affiliated to Tianjin Medical University, Tianjin, China

    1 shared publication

Latest Publications

  • A Model for Intracranial Bacterial Infection After Neurosurgery Integrating Bacterial Culture and Genetic Testing

    by Baoli Lin, Xianbing Meng, Ke Pu, Tao Fu, Nanyue Peng, Qingguo Li

    Background: Early diagnosis of intracranial bacterial infections following neurosurgical procedures remains challenging because of delayed or inconclusive pathogen identification. This study aimed to develop and validate a predictive model for early detection of post-neurosurgical procedure bacterial infections by integrating clinical features and cerebrospinal fluid (CSF) biomarkers. Methods: We conducted a retrospective study including 429 patients who underwent neurosurgery at Tianjin Huanhu Hospital between November 2018 and December 2024. Patients were randomly divided into training (n = 300) and validation (n = 129) cohorts. Predictive parameters were selected via uni-variable analysis and LASSO regression, followed by multi-variable logistic regression to construct a nomogram. Model performance was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis (DCA). Results: Among 429 patients, 147 (34.3%) had confirmed CSF bacterial infections. Seven independent predictors were identified: CSF time to operation, CSF color, CSF white blood cell count ≥ 2000 × 10 6 /L, CSF glucose < 1.89 mmol/L, CSF lactate concentration, hyperpyrexia, and slower reaction time. The model achieved an area under the ROC curve of 0.822 (95% confidence interval [CI]: 0.771–0.873) in the training cohort and 0.715 (95% CI: 0.604–0.827) in the validation cohort. DCA demonstrated substantial clinical net benefit across a threshold probability range of 0.1–0.25. Conclusion: This nomogram-based model provides a practical and reliable tool for early risk stratification of post-neurosurgical procedure intracranial bacterial infections, supporting timely diagnostic and therapeutic decision-making in clinical practice.

  • Open Access

    Early diagnostic strategy for central nervous system bacterial infections after neurosurgery: A retrospective study

    by Baoli Lin, Xianbing Meng, Ke Pu, Tao Fu, Nanyue Peng, Qingguo Li

    Accurate diagnosis of post-neurosurgical bacterial infection of central nervous system is challenging due to the nonspecific nature of clinical signs and cerebrospinal fluid (CSF) parameters, which often overlap with sterile postoperative inflammation. This study aimed to develop and validate a stepwise diagnostic strategy integrating readily available clinical and basic laboratory indicators to improve the early identification of post-neurosurgical bacterial infection of the central nervous system. A retrospective cohort study was conducted at Tianjin Huanhu Hospital, a tertiary neurosurgical center, from October 2018 to June 2025. We enrolled 176 patients suspected of post-neurosurgical bacterial infection of the central nervous system who underwent CSF metagenomic next-generation sequencing (mNGS). Six diagnostic prediction models, combining clinical features (fever, altered mental status) and CSF parameters (white blood cell count, glucose levels), were constructed. Their diagnostic performance was evaluated against a composite reference standard (mNGS, culture, and clinical treatment response) using receiver operating characteristic analysis. The area under the curve (AUC), sensitivity, and specificity were calculated. Among the 6 models, two demonstrated superior performance. Model 5 (T > 38.0°C + [CSF white blood cell ≥ 2000 × 10 6 /L OR CSF glucose < 2.2 mmol/L OR CSF/Blood glucose ratio < 0.4]) achieved an AUC of 0.768. Notably, Model 6 (T > 39.0°C + Altered Mental Status + Intermittent Fever), relying solely on clinical indicators, achieved a comparable AUC of 0.769. For individual parameters, a high fever threshold (T > 39.8°C) and profoundly low CSF glucose (<1.01 mmol/L) showed high specificities of 99%and 97%, respectively, for ruling in infection. A diagnostic strategy combining severe clinical manifestations (high fever and altered mental status) with high-threshold CSF parameters enables effective risk stratification for post-neurosurgical bacterial infection of the central nervous system. The high performance of a purely clinical model (Model 6) offers a valuable tool for rapid bedside assessment, especially in resource-limited settings. Future prospective, multicenter studies are recommended to validate these algorithms and further refine variable definitions for broader clinical application.